menu search

Recursion to participate in upcoming investor conferences

SALT LAKE CITY , Dec. 20, 2022 /PRNewswire/ --  Recursion (NASDAQ: RXRX), the clinical-stage biotechnology company industrializing drug discovery by ...

December 20, 2022, 7:55 am


Search within

Pages Search Results: